EQUITY RESEARCH MEMO

Onera Health

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)62/100

Onera Health is a Dutch digital health and medical device company pioneering a patch-based, wire-free polysomnography (PSG) system for at-home sleep diagnostics. Founded in 2016 and headquartered in Eindhoven, the company addresses the growing demand for convenient, clinical-grade sleep testing, aiming to replace traditional, cumbersome sleep lab studies. Onera's solution leverages a novel wearable patch that captures key sleep metrics without the need for wires or specialized facilities, improving patient comfort and access while maintaining diagnostic accuracy. With a focus on scalability and user experience, Onera is positioned to capture a significant share of the expanding sleep diagnostics market, which is driven by rising prevalence of sleep disorders such as sleep apnea and increasing preference for home-based testing.

Upcoming Catalysts (preview)

  • Q3 2026FDA Clearance for Onera's PSG System55% success
  • Q4 2026Strategic Partnership with Major U.S. Sleep Clinic Network45% success
  • H1 2027Reimbursement Code Approval for Home-Based PSG in Key European Markets60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)